The $300 billion pharmaceutical industry has grown significantly in the last decade and is expected to rise to $400 billion within three years. Advances in technology, drug development and therapeutics have shaped and improved the lives of billions of people. Our pharmaceutical clients invest much of their capital in drug research and development, and their innovations need experienced attorneys to protect their intellectual property assets.
Our pharmaceutical clients vary from venture-funded startups to large, renowned companies. We have experience in patent drafting and prosecution, licensing, ANDA filings and IPR petitions. Our firm also represents clients internationally, including multiple European and Australian Opposition proceedings as the opponent and patentee in areas related to nutraceuticals.
The firm professionals hold advanced degrees in molecular biology, organic chemistry, immunology and veterinary medicine, and can meet the needs of clients that create a variety of drug formulations. We have practice group members who have worked within the pharmaceutical and biomedical industry, including a cancer researcher. Our professionals’ legal experience in therapeutics, diagnostics, biopharmaceuticals, immunogenetics, infectious disease and drug delivery provide the background to aid our clients in patent protection, counseling and litigation. We offer solid, skilled expertise to clients in the expanding pharmaceutical industry.